Abstract: The application provides a display substrate, a method for manufacturing the same, and a display device. The display substrate includes a display region and a binding region located at a periphery of the display region. The binding region is provided with a drive circuit pin and a flexible circuit board pin, and a connecting trace for connecting the drive circuit pin and the flexible circuit board pin. The connecting trace includes a first connecting line and a second connecting line connected in parallel, the first connecting line and the second connecting line are in different layers, the first connecting line is between an interlayer insulating layer and a base substrate of the display substrate, the first connecting line and the interlayer insulating layer are separated by a first insulating layer, and the second connecting line is on a side of the interlayer insulating layer away from the base substrate.

Abstract: The present disclosure provides a speaker diaphragm and a speaker. The diaphragm includes a thermoplastic polyester elastomer film layer, a thermoplastic polyester elastomer being a copolymer composed of a hard segment A of polyester and a soft segment B of polyether or aliphatic polyester, wherein the thermoplastic polyester elastomer film layer has Young's modulus of 1-1000 MPa, with an elastic recovery rate after 10% strain being greater than or equal to 80%. The speaker diaphragm has a good stiffness, a good damping performance and a good resilience.

Abstract: A method for evaluating a downhole working condition of a PDC bit includes: performing an indoor test, including performing a drilling test in different full-sized cores by using the PDC bit with different degrees of abrasion and balling under condition of given WOB and rotational speed, to acquire change characteristics of a WOB, a rotational speed, a torque, a ROP and a bit vibration of the PDC bit in different time domains; improving and perfecting an existing prediction model and evaluation method for the downhole working condition through data obtained by the test to obtain the method; reading parameters of the WOB, the rotational speed, the torque and the ROP in real time during drilling; determining the downhole working condition of the PDC bit by using the method in the improving and perfecting.

Abstract: Embodiments of the present disclosure relate to multimedia processing method, apparatus, device and medium, wherein the method includes: presenting a first multimedia interface comprising first content; receiving an interface switching request of a user in the first multimedia interface; and switching from the first multimedia interface currently presented to a second multimedia interface, and presenting second content in the second multimedia interface, wherein the first content comprises the second content and other content associated with the second content, and the second content comprises a target audio and a target subtitle corresponding to the target audio.

Abstract: A low-heat-loss operation method of a line-focusing heat collection system and the line-focusing heat collection system are provided. The method includes the following steps. Solar energy is utilized to preheat a collector tube in an empty tube state, so that the collector tube is in a preheating mode. After a set preheating temperature is reached, a heat transfer working medium is injected into the collector tube. In the injection process of the heat transfer working medium, an injection section of the collector tube is converted into a focusing mode from a preheating mode. After heat collection is finished, the circulation of the heat transfer working medium is stopped, and the focusing mode of the collector tube is kept. In the drainage process of the heat transfer working medium, an emptying section of the collector tube is converted into a light heat-tracing mode from a focusing mode.

Abstract: A hierarchical health index evaluation method for an intelligent substation includes: obtaining a basic health index of a device based on static information and dynamic information of the device; obtaining a device correlation based on a communication connection relationship between the device and another device, and correcting the basic health index of the device based on the device correlation to obtain a health index of the device; obtaining a layer-based health index of a layer based on a device health index and a device importance weight of the layer; obtaining a whole-station health index of an intelligent substation based on a layer-based health index of each layer and a sum of device importance weights of each layer; and regulating the intelligent substation based on a health index of each device in the intelligent substation, the layer-based health index of each layer, and the whole-station health index.

Abstract: This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.

Abstract: A display substrate, a test method for the display substrate and a display device are provided. The display substrate includes a base substrate, a touch detection circuit layer and a pixel driving circuit layer. The display substrate includes a display region and a non-display region surrounding the display region. The touch detection circuit layer includes a driving signal line and a dummy electrode line arranged side by side in the display region and insulated from each other, and both the driving signal line and the dummy electrode line extend from the display region to the non-display region. The non-display region is provided with a plurality of test pads including a first pad electrically connected to the driving signal line and a second pad electrically connected to the dummy electrode line.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: Disclosed is an amorphous nanocrystalline alloy strip. When the amorphous nanocrystalline alloy strip is cut into a plurality of narrow strips having a same width of less than or equal to 10 mm, a relative length difference among the plurality of narrow strips is not greater than 0.50%. Further disclosed is a method for manufacturing the amorphous nanocrystalline alloy strip. The amorphous nanocrystalline alloy strip has good surface flatness. The transverse temperature non-uniformity of molten steel inside a melting pool and the surface temperature non-uniformity of a cooling roller within a strip manufacturing position range are controlled in a process of manufacturing the amorphous nanocrystalline alloy strip, so that the surface flatness of the manufactured strip is improved. The manufacturing process is simple and convenient.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: An alkali-free ultrafine glass fiber formula includes the following components, in mass percentage calculated based on 100 Kg: SiO2: 50% to 65%, Al2O3: 10% to 16.5%, CaO: 17% to 28%, MgO: 0.2% to 4.0%, Na2O and K2O: 0.1% to 0.8% in total, CeO2: 0.1% to 0.5%, Li2O: 0.1% to 0.7%, Fe2O3: 0.05% to 0.6%, TiO2: 0.1% to 1%, and impurities: the balance. In the preparation of alkali-free ultrafine glass fibers, no fluorine and boron-containing raw materials are used, and CeO2 and Li2O are introduced, which avoids the use of B2O3 and F that have a large impact on the environment, and reduces environmental pollution. A single fiber strength of prepared glass fibers is about 9% higher than that of the traditional E glass fibers, and the comprehensive performance of a prepared glass fiber product is significantly superior than that of the existing E glass fiber product.

Abstract: Embodiments of the present application provide a method for predicting envelope features. The method includes: according to baseband data or data after modulation mapping, a peak value of a radio frequency envelope signal, a time point corresponding to the peak value, a valley point of the radio frequency envelope signal and a time point corresponding to the valley point are predicted; according to the valley point and the time point corresponding thereto, a generated reference value is sent to a low-bandwidth control signal generating module to obtain a control signal; according to adjacent valley point and peak point, and time points corresponding thereto, generated status information is sent to a high-bandwidth control signal generating module to obtain a control switch signal; and when in an ascending status, according to a key information string, a slope k of a connecting line is determined, and a corresponding filter inductor is turned on.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.

Abstract: The present embodiments are directed, in part, to 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, such as those of Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinson's Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: A controller groups a plurality of service application types into a plurality of application type groups based on link quality requirements of the plurality of service application types in a network; determines sending priorities based on the plurality of application type groups; separately determines at least one link for the plurality of application type groups based on link quality requirements of the plurality of application type groups and link quality information of a plurality of links in the network; separately determines network configurations for the plurality of application type groups based on the at least one link separately determined for the plurality of application type groups, the sending priorities of the plurality of application type groups, the link quality requirements of the plurality of application type groups, and a policy recommendation engine; and delivers the network configurations to a policy execution point device.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: Disclosed herein is a display panel, comprising: a support; a first layer comprising a light emitter, a first region and a second region; a second layer sandwiched between the first layer and the support; wherein the first region and the second region allow light scattered by an object (e.g., a person's finger) to transmit therethrough; wherein the second layer allows light transmitted through the first region to reach the support and comprises a light-blocking layer configured to attenuate light transmitted through the second region.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.